---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-000659"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2023-02-03T23:59:59+00:00"
generated_at: "2026-06-20T00:57:14.216017+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology appoints Pamela Bush as Chief Business Officer

## Summary
- Pamela Bush, Ph.D., MBA, appointed Chief Business Officer effective Jan. 30, 2023.
- Bush previously served as SVP of Strategic Sales and Business Development since Dec. 2021.
- She brings 20+ years experience in life sciences venture creation and business development.
- Prior roles include Director of Corporate Business Development at Eli Lilly & Company.

## SEC filing metadata
- accession: 0001171843-23-000659
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2023-02-03T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184323000659/0001171843-23-000659-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184323000659/f8k_020323.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-000659
- JSON: https://secwatch.observer/filing/0001171843-23-000659.json
- Plain text: https://secwatch.observer/filing/0001171843-23-000659.txt

## Key facts
- Executive change
  Pamela Bush was appointed as Chief Business Officer at Axe Compute Inc..
  - Action: appointed
  - Role: Chief Business Officer
  source text: On January 30, 2023, the Board of Directors of Predictive Oncology Inc. (the “Company”) appointed Pamela Bush, Ph.D., MBA, age 49, as Chief Business Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184323000659/0001171843-23-000659-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.